A type of lipid-lowering drug.
A family of related drugs used to treat hypercholesterolaemia. They act by inhibiting hydroxymethylglutaryl CoA reductase (HMG CoA reductase), the first and rate-limiting enzyme of cholesterol synthesis.
A lipid-lowering drug which inhibits an enzyme in cholesterol synthesis, used to treat people with, or at high risk of developing, coronary heart disease.